INTERNATIONAL PATENT: IMMATICS BIOTECHNOLOGIES GMBH, IMMATICS US, INC. FILES APPLICATION FOR "USE AND DOSAGE OF AN ANTIGEN-BINDING PROTEIN COMPRISING A TCR SPECIFIC FOR AN HLA-A*02 RESTRICTED PEPTIDE"

GENEVA, Nov. 17 -- IMMATICS BIOTECHNOLOGIES GMBH (Paul-Ehrlich-Str. 1572076 Tubingen), IMMATICS US, INC. (13203 Murphy RoadStafford, Texas 77477) filed a patent application (PCT/EP2025/062557) for "USE AND DOSAGE OF AN ANTIGEN-BINDING PROTEIN COMPRISING A TCR SPECIFIC FOR AN HLA-A*02 RESTRICTED PEPTIDE" on May 07, 2025. With publication no. WO/2025/233432, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HILF, Norbert (c/o Immatics Biotechnologies GmbHPaul-Ehrlich-Str. 1572076 Tubingen), MISSEL, Sarah (c/o Immatics Biotech...